T
Thorsten Persigehl
Researcher at Columbia University
Publications - 5
Citations - 225
Thorsten Persigehl is an academic researcher from Columbia University. The author has contributed to research in topics: PET-CT & Mesothelioma. The author has an hindex of 4, co-authored 5 publications receiving 206 citations. Previous affiliations of Thorsten Persigehl include University of Münster & Seoul National University.
Papers
More filters
Journal ArticleDOI
Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
Hyun Ju Lee,Young Tae Kim,Chang Hyun Kang,Binsheng Zhao,Yongqiang Tan,Lawrence H. Schwartz,Thorsten Persigehl,Thorsten Persigehl,Thorsten Persigehl,Yoon Kyung Jeon,Doo Hyun Chung +10 more
TL;DR: GGO volume percentage in tumors with exon 21 missense mutation was significantly higher than that in tumor status with other EGFR mutation status, and can be related to the fact that exon21 missense mutations was significantly more frequent in lepidic predominant adenocarcinomas, according to IASLE/ATS/ERS classification.
Journal ArticleDOI
Imaging in pleural mesothelioma: A review of the 11th International Conference of the International Mesothelioma Interest Group
Samuel G. Armato,Zacariah E. Labby,Johan Coolen,Astero Klabatsa,M. Feigen,Thorsten Persigehl,Ritu R. Gill +6 more
TL;DR: The measurement of tumor thickness on computed tomography (CT) scans is the current standard of care in the assessment of MPM tumor response to therapy and variability among observers in the measurement task and in the tumor response classification categories derived from such measurements was reported.
Journal ArticleDOI
Variability in Assessing Treatment Response: Metastatic Colorectal Cancer as a Paradigm
Binsheng Zhao,Shing M. Lee,Hyun Ju Lee,Yongqiang Tan,Jing Qi,Thorsten Persigehl,David P. Mozley,Lawrence H. Schwartz +7 more
TL;DR: The relatively low variability in change of mCRC measurements suggests that response criteria could be modified to allow more accurate and sensitive CT assessment of anticancer therapy efficacy.
Journal ArticleDOI
Concurrent MR blood volume and vessel size estimation in tumors by robust and simultaneous ΔR2 and ΔR2* quantification
Stefanie Remmele,Janine Ring,Julien Senegas,Walter Heindel,Rolf M. Mesters,Christoph Bremer,Thorsten Persigehl,Thorsten Persigehl +7 more
TL;DR: The simultaneous blood volume and vessel size estimates compare well to the immunohistological findings in a preclinical experiment (HT1080 cells, implanted in nude mice) and clinical translation is achieved in a patient with a pleomorphic sarcoma in the left pubic bone.